516 related articles for article (PubMed ID: 24438112)
21. Phosphatidylethanol Compared with Other Blood Tests as a Biomarker of Moderate Alcohol Consumption in Healthy Volunteers: A Prospective Randomized Study.
Kechagias S; Dernroth DN; Blomgren A; Hansson T; Isaksson A; Walther L; Kronstrand R; Kågedal B; Nystrom FH
Alcohol Alcohol; 2015 Jul; 50(4):399-406. PubMed ID: 25882743
[TBL] [Abstract][Full Text] [Related]
22. Alcohol drinking, mean corpuscular volume of erythrocytes, and alcohol metabolic genotypes in drunk drivers.
Pavanello S; Snenghi R; Nalesso A; Sartore D; Ferrara SD; Montisci M
Alcohol; 2012 Feb; 46(1):61-8. PubMed ID: 21917409
[TBL] [Abstract][Full Text] [Related]
23. Use of carbohydrate-deficient transferrin (CDT) and a combination of GGT and CDT (GGT-CDT) to assess heavy alcohol consumption in traffic medicine.
Bianchi V; Ivaldi A; Raspagni A; Arfini C; Vidali M
Alcohol Alcohol; 2010; 45(3):247-51. PubMed ID: 20118108
[TBL] [Abstract][Full Text] [Related]
24. Phosphatidylethanol as a sensitive and specific biomarker: comparison with gamma-glutamyl transpeptidase, mean corpuscular volume and carbohydrate-deficient transferrin.
Hartmann S; Aradottir S; Graf M; Wiesbeck G; Lesch O; Ramskogler K; Wolfersdorf M; Alling C; Wurst FM
Addict Biol; 2007 Mar; 12(1):81-4. PubMed ID: 17407500
[TBL] [Abstract][Full Text] [Related]
25. Comparative performance of biomarkers of alcohol consumption in a population sample of working-aged men in Russia: the Izhevsk Family Study.
McDonald H; Borinskya S; Kiryanov N; Gil A; Helander A; Leon DA
Addiction; 2013 Sep; 108(9):1579-89. PubMed ID: 23692391
[TBL] [Abstract][Full Text] [Related]
26. Could trisialotransferrin be used as an additional biomarker to CDT in order to improve detection of chronic excessive alcohol intake?
Tamigniau A; Wallemacq P; Maisin D
Clin Biochem; 2014 Sep; 47(13-14):1203-8. PubMed ID: 24863961
[TBL] [Abstract][Full Text] [Related]
27. Quantification of EtG in hair, EtG and EtS in urine and PEth species in capillary dried blood spots to assess the alcohol consumption in driver's licence regranting cases.
Kummer N; Wille SM; Poll A; Lambert WE; Samyn N; Stove CP
Drug Alcohol Depend; 2016 Aug; 165():191-7. PubMed ID: 27364378
[TBL] [Abstract][Full Text] [Related]
28. Blood biomarkers of alcohol abuse.
Bilban M; Vrhovec S; Karlovsek MZ
Arh Hig Rada Toksikol; 2003 Dec; 54(4):253-9. PubMed ID: 14994647
[TBL] [Abstract][Full Text] [Related]
29. Laboratory markers carbohydrate-deficient transferrin, gamma-glutamyltransferase, and mean corpuscular volume are not useful as screening tools for high-risk drinking in the general population: results from the Study of Health in Pomerania (SHIP).
Alte D; Luedemann J; Rose HJ; John U
Alcohol Clin Exp Res; 2004 Jun; 28(6):931-40. PubMed ID: 15201636
[TBL] [Abstract][Full Text] [Related]
30. Carbohydrate-deficient transferrin (CDT) as a biomarker in persons suspected of alcohol abuse.
Golka K; Sondermann R; Reich SE; Wiese A
Toxicol Lett; 2004 Jun; 151(1):235-41. PubMed ID: 15177658
[TBL] [Abstract][Full Text] [Related]
31. Combinations of carbohydrate-deficient transferrin, mean corpuscular erythrocyte volume, gamma-glutamyltransferase, homocysteine and folate increase the significance of biological markers in alcohol dependent patients.
Rinck D; Frieling H; Freitag A; Hillemacher T; Bayerlein K; Kornhuber J; Bleich S
Drug Alcohol Depend; 2007 Jun; 89(1):60-5. PubMed ID: 17234365
[TBL] [Abstract][Full Text] [Related]
32. The diagnostic accuracy of carbohydrate-deficient transferrin, sialic acid and commonly used markers of alcohol abuse during abstinence.
Chrostek L; Cylwik B; Szmitkowski M; Korcz W
Clin Chim Acta; 2006 Feb; 364(1-2):167-71. PubMed ID: 16087169
[TBL] [Abstract][Full Text] [Related]
33. DOVER and QUVER-new marker combinations to detect and monitor at-risk drinking.
Berner MM; Bentele M; Kriston L; Mänz C; Clement HW; Härter M; Mundle G
Alcohol Clin Exp Res; 2006 Aug; 30(8):1372-80. PubMed ID: 16899040
[TBL] [Abstract][Full Text] [Related]
34. Measurement of direct ethanol metabolites in a case of a former driving under the influence (DUI) of alcohol offender, now claiming abstinence.
Wurst FM; Yegles M; Alling C; Aradottir S; Dierkes J; Wiesbeck GA; Halter CC; Pragst F; Auwaerter V
Int J Legal Med; 2008 May; 122(3):235-9. PubMed ID: 18253745
[TBL] [Abstract][Full Text] [Related]
35. Relationship between carbohydrate-deficient transferrin, gamma-glutamyl transferase, and mean corpuscular volume levels and alcohol-related brain volume decreases in male drinkers.
de Bruin EA; Lemmens PH; Hulshoff Pol HE; Verbaten MN; Kenemans JL
Hum Psychopharmacol; 2012 Nov; 27(6):559-65. PubMed ID: 23027680
[TBL] [Abstract][Full Text] [Related]
36. [Evaluation of an increased blood level of GGT, CDT, methanol, acetone and isopropanol in alcohol intoxicated automobile drivers. Alcoholism indicators instead of medical-psychological examination].
Iffland R; Balling MP; Börsch G; Herold C; Kaschade W; Löffler T; Schmidtmann U; Stettner J
Blutalkohol; 1994 Sep; 31(5):273-314. PubMed ID: 7986482
[TBL] [Abstract][Full Text] [Related]
37. Use of laboratory markers and the audit questionnaire by primary care physicians to detect alcohol abuse by patients.
Aalto M; Seppä K
Alcohol Alcohol; 2005; 40(6):520-3. PubMed ID: 16215269
[TBL] [Abstract][Full Text] [Related]
38. Concentrations of carbohydrate-deficient transferrin in dialysed plasma from drunken drivers.
Gjerde H; Mørland J
Alcohol Alcohol; 1987; 22(3):271-6. PubMed ID: 2887174
[TBL] [Abstract][Full Text] [Related]
39. Carbohydrate-deficient transferrin (CDT)--a biomarker for long-term alcohol consumption.
Golka K; Wiese A
J Toxicol Environ Health B Crit Rev; 2004; 7(4):319-37. PubMed ID: 15205047
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the combined marker GGT-CDT and the conventional laboratory markers of alcohol abuse in heavy drinkers, moderate drinkers and abstainers.
Hietala J; Koivisto H; Anttila P; Niemelä O
Alcohol Alcohol; 2006; 41(5):528-33. PubMed ID: 16799164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
